Evidence map›Paper›PMID 42252508›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Differential associations of plasma biomarkers with Alzheimer's disease and small vessel disease: A multimodal imaging study.

Anna Dewenter, Katharina Bürger, Daniel Janowitz, Melina Paulus, Brigitte Nuscher, Fabian Hirsch, Benno Gesierich, Anna Steward, Lukas Frontzkowski, Sebastian N Roemer-Cassiano and 11 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Anna DewenterInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Katharina BürgerInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Daniel JanowitzInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Melina PaulusInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Brigitte NuscherDivision of Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Fabian HirschInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Benno GesierichAntaros Medical AB, Mölndal, Sweden.
Anna StewardInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Lukas FrontzkowskiInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Sebastian N Roemer-CassianoInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Zeyu ZhuInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Davina BielInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Madleen KlonowskiInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Gloria BiecheleDepartment of Radiology, University Hospital, LMU Munich, Munich, Germany.
Sophia StoeckleinDepartment of Radiology, University Hospital, LMU Munich, Munich, Germany.
Michael EwersInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Marco DueringInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Steffen TiedtInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Matthias BrendelGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Nicolai FranzmeierInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Alzheimer's Disease Neuroimaging Initiative (ADNI)

Funding

Legerlotz Stiftung 1032Legerlotz Stiftung 1175
6 · The paper itself

Abstract

introductionWe investigated how plasma biomarkers (phosphorylated tau 217 [ptau

methods76 memory clinic patients underwent plasma biomarker assessment, neuropsychological testing, and 3T MRI. SVD burden was assessed using white matter hyperintensity (WMH) volume, mean skeletonized mean diffusivity (MSMD), and fiber density. AD-related neurodegeneration was captured by AD-signature cortical thickness and fiber-bundle cross-section. Findings were validated in 41 Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with amyloid-/tau-positron emission tomography (PET).

resultsAssociations varied between biomarkers. NfL showed strongest associations with SVD burden, ptau DISCUSSION: NfL relates to SVD burden, while ptau

Indexed as

Alzheimer DiseaseBiomarkersCerebral Small Vessel DiseasesGlial Fibrillary Acidic ProteinAgedAged, 80 and overFemaleHumansMagnetic Resonance ImagingMaleMultimodal ImagingNeurofilament ProteinsNeuropsychological TestsPositron-Emission Tomographytau ProteinsBiomarkersGlial Fibrillary Acidic Proteinneurofilament protein LNeurofilament Proteinstau ProteinsAlzheimer's diseasebiomarkerscerebral small vessel diseaseimagingimaging biomarkersmixed pathologyplasma biomarkersprecision medicine

Identifiers

PMID42252508
PMCPMC13243208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.